Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Chembio Diagnostics, Inc. CEMI
$0.46
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
16710285.00000000
-
week52high
1.24
-
week52low
0.19
-
Revenue
48339900
-
P/E TTM
0
-
Beta
1.85709300
-
EPS
-0.72000000
-
Last Dividend
0.00000000
-
Next Earnings Date
03 мая 2023 г. в 10:59
Описание компании
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Canaccord Genuity | Hold | Buy | 17 июн 2020 г. |
| Benchmark | Hold | Speculative Buy | 17 июн 2020 г. |
| Baird | Outperform | 26 мая 2020 г. | |
| Canaccord Genuity | Buy | Buy | 16 апр 2020 г. |
| Benchmark | Speculative Buy | Speculative Buy | 01 апр 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Teso-Lichtman Leslie | A | 82286 | 82286 | 27 июн 2022 г. |
| Teso-Lichtman Leslie | A | 64000 | 64000 | 27 июн 2022 г. |
| Teso-Lichtman Leslie | A | 41143 | 41143 | 24 мая 2022 г. |
| Teso-Lichtman Leslie | A | 32000 | 32000 | 24 мая 2022 г. |
| Bespalko David William | A | 41143 | 41143 | 11 мар 2022 г. |
| Bespalko David William | A | 32000 | 32000 | 11 мар 2022 г. |
| Acheson David | A | 41143 | 41143 | 11 мар 2022 г. |
| Acheson David | A | 32000 | 32000 | 11 мар 2022 г. |
| Davis Katherine Lyon | A | 41143 | 41143 | 11 мар 2022 г. |
| Davis Katherine Lyon | A | 32000 | 32000 | 11 мар 2022 г. |
Новостная лента
10 Best-Performing Penny Stocks in the Health Care Sector
24/7 Wall Street
03 апр 2023 г. в 22:49
The healthcare sector has more high return generating companies than many other sectors.
Chembio Diagnostics, Inc. (CEMI) Q3 2022 Earnings Call Transcript
Seeking Alpha
06 ноя 2022 г. в 10:18
Chembio Diagnostics, Inc. (NASDAQ:CEMI ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Philip Taylor - Investor Relations Rick Eberly - President & Chief Executive Officer Larry Steenvoorden - Executive Vice President & Chief Financial Officer Conference Call Participants Per Ostlund - Craig-Hallum Operator Good afternoon, ladies and gentlemen, and welcome to the Chembio Diagnostics Third Quarter 2022 Earnings Conference Call and Webcast. At this time, all participants have been placed in a listen-only mode and the floor will be open for questions after the presentation.
Chembio Diagnostics to Report Third Quarter 2022 Financial Results on November 3, 2022
GlobeNewsWire
20 окт 2022 г. в 16:05
HAUPPAUGE, N.Y., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the third quarter of 2022 after the close of trading on Thursday, November 3, 2022.
Trending Penny Stocks For Your September Watchlist
PennyStocks
02 сент 2022 г. в 06:00
Here's what you need to know about trading penny stocks on September 2nd The post Trending Penny Stocks For Your September Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Chembio Diagnostics, Inc.'s (CEMI) CEO Rick Eberly on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
07 авг 2022 г. в 14:19
Chembio Diagnostics, Inc. (NASDAQ:CEMI ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Philip Taylor - Investor Relations Rick Eberly - President and CEO Larry Steenvoorden - Chief Financial Officer Conference Call Participants Per Ostlund - Craig-Hallum Operator Good afternoon, ladies and gentlemen. And welcome to the Chembio Second Quarter 2022 Earnings Conference Call.